Loading...
Switching from Dupilumab to Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Podcast Article
Abstract As the number of systemic agents available for the treatment of moderate-to-severe atopic dermatitis (AD) continues to increase, it is likely that patients may need or want to switch from one treatment to another. Owing to differences in the mechanism of action, the systemic agents abrociti...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Adis, Springer Healthcare
2025-08-01
|
| Series: | Dermatology and Therapy |
| Online Access: | https://doi.org/10.1007/s13555-025-01491-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|